MGNX
Price
$1.71
Change
-$0.00 (-0.00%)
Updated
Apr 24, 02:37 PM (EDT)
Capitalization
95.9M
19 days until earnings call
ORMP
Price
$2.32
Change
+$0.01 (+0.43%)
Updated
Apr 24, 02:35 PM (EDT)
Capitalization
93.55M
34 days until earnings call
Ad is loading...

MGNX vs ORMP

Header iconMGNX vs ORMP Comparison
Open Charts MGNX vs ORMPBanner chart's image
MacroGenics
Price$1.71
Change-$0.00 (-0.00%)
Volume$700
Capitalization95.9M
Oramed Pharmaceuticals
Price$2.32
Change+$0.01 (+0.43%)
Volume$200
Capitalization93.55M
MGNX vs ORMP Comparison Chart
Loading...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGNX vs. ORMP commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Buy and ORMP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (MGNX: $1.71 vs. ORMP: $2.31)
Brand notoriety: MGNX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 131% vs. ORMP: 12%
Market capitalization -- MGNX: $95.9M vs. ORMP: $93.55M
MGNX [@Biotechnology] is valued at $95.9M. ORMP’s [@Biotechnology] market capitalization is $93.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • MGNX’s TA Score: 4 bullish, 4 bearish.
  • ORMP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than MGNX.

Price Growth

MGNX (@Biotechnology) experienced а +44.49% price change this week, while ORMP (@Biotechnology) price change was +4.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

MGNX is expected to report earnings on Aug 12, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($95.9M) and ORMP($93.5M) have the same market capitalization . ORMP YTD gains are higher at: -4.752 vs. MGNX (-47.538). ORMP has higher annual earnings (EBITDA): 9.44M vs. MGNX (-89.09M). MGNX has more cash in the bank: 200M vs. ORMP (142M). ORMP has less debt than MGNX: ORMP (429K) vs MGNX (34.1M). MGNX has higher revenues than ORMP: MGNX (140M) vs ORMP (0).
MGNXORMPMGNX / ORMP
Capitalization95.9M93.5M103%
EBITDA-89.09M9.44M-944%
Gain YTD-47.538-4.7521,000%
P/E RatioN/A20.91-
Revenue140M0-
Total Cash200M142M141%
Total Debt34.1M429K7,949%
FUNDAMENTALS RATINGS
MGNX vs ORMP: Fundamental Ratings
MGNX
ORMP
OUTLOOK RATING
1..100
1711
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9580
PRICE GROWTH RATING
1..100
9570
P/E GROWTH RATING
1..100
9540
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (67) in the Pharmaceuticals Other industry is in the same range as MGNX (81) in the Biotechnology industry. This means that ORMP’s stock grew similarly to MGNX’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as MGNX (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to MGNX’s over the last 12 months.

ORMP's SMR Rating (80) in the Pharmaceuticals Other industry is in the same range as MGNX (95) in the Biotechnology industry. This means that ORMP’s stock grew similarly to MGNX’s over the last 12 months.

ORMP's Price Growth Rating (70) in the Pharmaceuticals Other industry is in the same range as MGNX (95) in the Biotechnology industry. This means that ORMP’s stock grew similarly to MGNX’s over the last 12 months.

ORMP's P/E Growth Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for MGNX (95) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than MGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGNXORMP
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JSDA0.210.01
+5.00%
Jones Soda Co.
OPHLY4.150.09
+2.22%
Ono Pharmaceutical Co., Ltd.
SCGLY9.520.18
+1.93%
Societe Generale
ENLAY8.46-0.06
-0.70%
ENEL Societa per Azioni
BRCHF0.17N/A
-2.78%
Brainchip Holdings Ltd.

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with AMRN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+12.17%
AMRN - MGNX
44%
Loosely correlated
-1.24%
IOVA - MGNX
40%
Loosely correlated
-0.62%
ATOS - MGNX
38%
Loosely correlated
+11.25%
ORMP - MGNX
34%
Loosely correlated
+0.66%
ARWR - MGNX
33%
Loosely correlated
+5.26%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.66%
BTAI - ORMP
44%
Loosely correlated
+0.60%
INO - ORMP
44%
Loosely correlated
+0.81%
MBIO - ORMP
44%
Loosely correlated
+7.21%
VERV - ORMP
44%
Loosely correlated
+3.81%
ZNTL - ORMP
43%
Loosely correlated
+1.70%
More